The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Sanz R
- Navarro D
Grupos
Abstract
There is a lack of studies comparing clinical outcomes among retrospective versus prospective cohorts of allogeneic stem cell transplant (allo-HCT) recipients with community acquired respiratory virus (CARV) infections.
Datos de la publicación
- ISSN/ISSNe:
- 0163-4453, 1532-2742
- Tipo:
- Article
- Páginas:
- 333-341
- PubMed:
- 31972212
- Factor de Impacto:
- 1,946 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF INFECTION W B SAUNDERS CO LTD
Citas Recibidas en Web of Science: 11
Documentos
- No hay documentos
Filiaciones
Keywords
- Allogeneic hematopoietic stem cell transplantation, Community-acquired respiratory virus, Immunodeficiency score index, Influenza, Parainfluenza virus, Prospective respiratory virus surveillance program, Respiratory syncytial virus, Respiratory virus infection
Cita
PIÑANA J,MONTORO J,AZNAR C,LORENZO I,GÓMEZ MD,GUERREIRO M,CARRETERO C,GONZÁLEZ EM,BALAGUER A,Sanz R,SALAVERT M,Navarro D,SANZ MA,SANZ G,SANZ J. The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation. J. Infect. 2020. 80. (3):p. 333-341. IF:6,072. (1).
Portal de investigación